RHS signs with Medicare for distribution of EmbryoCellect™ in China, Hong Kong and Macau
Jul 14, 2015 -
Reproductive Health Science Limited (ASX: RHS) (“RHS” or “the Company”) is pleased to announce that it has signed an exclusive distribution agreement with Medicare International Trading Limited for the sale of EmbryoCellect™ in China, Hong Kong and Macau. Medicare is based in Hong Kong and distributes in mainland China through its Chinese company, Miaoquan Enterprise, which is based in Shenzhen. Miaoquan is a key distributor in the field of assisted reproductive medicine, distributing a range of consumables and equipment in these territories for many major international suppliers.
Read the full announcement here.